VIR

AS OF

Dec 24 closing price

Price

$6.11

Change

+$0.12 (+2.00%)

Capitalization

850.05M

56 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

VIR

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Vir Biotechnology (VIR) Ownership - Who owns Vir Biotechnology?

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

1800 Owens Street

Phone

+1 415 906-4324

Employees

587

Web

https://www.vir.bio

Details

Group

Domestic Stock Funds

Fundamentals

VIR

Capitalization

850M

P/E Ratio

N/A

Risk (Beta)

2.16

Dividend Yield

N/A

Total Cash

507M

Total Cash/Share

3.64

Total Debt

100M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.10%

Revenue

14M

ROE

N/A

Book Value

796M

P/B Ratio

1.07

Cash Flow

N/A

Earnings

-3.62

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

14K

Current Ratio

7.25

Current Revenue Per Employee

2526.96

Dividends Per Share - Security

N/A

EBITDA

-541.01M

Float

N/A

Float - Current

N/A

Gross Income Margin

98.93

Revenue To Assets

-39.69

Shares Held By Institutions

865M

Shares Outstanding - Current

139M

Total Liabilities

223M

Total Volume MTD

N/A

Value

N/A

Gain YTD

-16.757

View a ticker or compare two or three

Compare

Choppy Market Trader for Beginners: Hi-tech Stocks (TA&FA)
60min Choppy Market Trader for Beginners: Hi-tech Stocks (TA&FA)
60min

Annualized Return+87%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

VIR

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. VIR showed earnings on November 05, 2025. You can read more about the earnings report here.

View AI-Driven Trading for VIR

A.I. Advisor

published General Information

General Information

a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases

Industry Biotechnology